Is there a place for crizotinib in c-MET alterations? A...

Is there a place for crizotinib in c-MET alterations? A case of efficacy in ALK positive NSCLC patient with secondary c-MET amplification

Mazzotta, M., Filetti, M., Rossi, A., Roberto, M., Occhipinti, M., Pernazza, A., Di Napoli, A., Scarpino, S., Vecchione, A., Giusti, R., Marchetti, P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2019.11.016
Date:
March, 2020
File:
PDF, 801 KB
2020
Conversion to is in progress
Conversion to is failed